PGP and cancer: In addition, when we increased the concentrations of sorafenib and regorafenib to 10 μM, we found that late apoptosis was notably increased (Figures 2D,E), suggesting that these drugs can sensitize P-gp-overexpressing resistant KBV20C cancer cells at higher doses.